Researchers Highlight Important Advancements in Understanding Value Emerging from the Pandemic Alexandria, VA — November 10, 2020 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today released its latest Value Blueprints research brief recommending key areas for adapting [...]
PRESS RELEASE: IVI Selects Pharmerit to Construct Foundation of Major Depressive Disorder Value Assessment Model
Health Economics Experts to Work with IVI-convened Advisory Group to Assess and Determine Model Inputs October 20, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI)— a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare—today announced it has selected Pharmerit - an OPEN Health Company, as [...]
For our first Member Spotlight, we chatted with Dr. Wayne Burton about what he sees as the future of value assessment. Dr. Burton has been with IVI almost since its inception. This interview is an adaptation of a conversation we had with Dr. Burton this fall. Tell us a little about yourself and [...]
We, at the Innovation and Value Initiative, are deeply appreciative and excited about the growing number of members who share our commitment to advancing the science of value assessment. As part of our Value Source Blog, we are introducing our Member Spotlight series, where we talk with IVI members about the future of value assessment [...]
Author: Jennifer Bright, MPA, Executive Director, IVI For decades, we've known that untreated or poorly treated Major Depressive Disorder (MDD) is an enormous burden on individual patients, our health care system, and our society. Despite having this knowledge, there is much work to do in order to support and optimize cost-effective care for patients suffering [...]
First of Its Kind Depression Model to be Informed by Input from Diverse Advisory Group September 9, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI) — a non-profit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today announced a multi-year initiative to build and test [...]
IVI and the University of Maryland Pharmacy School’s PAVE Center Partner on Patient-Centered Value Assessment
In an article in The Patient, IVI and the Patient-Driven Values in Healthcare Evaluation (PAVE) Center at the University of Maryland School of Pharmacy describe how they develop methods and models that make patient-centered value assessment both scientifically feasible and relevant to real-world decisions across the range of stakeholders. Read the full article here.
Second Webinar in the ISPOR-IVI Series Explores Whether Value Assessments are Up to the Task in the Age of COVID-19
The second part of a five-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to task or in need of improvement for the pandemic era. Moderated by Lou Garrison, PhD (University [...]
Author: Jennifer Bright, MPA Everyone hopes for a COVID vaccine so our lives can return to normal. Yet, we know that even if clinical trials prove a vaccine's effectiveness, our society will still have to endure a long process of distribution. I'm personally willing to wait for a vaccine for healthcare workers, the elderly, and [...]
IVI is pleased to share our Annual Report that documents the transition of our organization to an independent, 501c(3) organization, describes our membership and patient engagement strategies, and offers highlights and learnings from research and convening activities over the past 18 months.